Noveris Health Sciences is trading at CA$0.09, down -5.26%, as broader risk-off pressure intensified on September 10, 2026. - U.S. indices are down more than 0.5% as hotter August producer inflation raises rate concerns. - No company-specific catalyst was identified; the latest announcement reported shareholder approval of all AGM resolutions. - The decline follows losses on September 8 and September 9.